companydata.dkcompanydata.dk

Clovis Oncology Denmark ApS: Financial statements 2023

CVR: 38721682

Source: annual report 2023, Danish Business Authority

01/01/2023 – 31/12/2023

Clovis Oncology Denmark ApS (CVR 38721682) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -1,276,497 and a net result of DKK -1,290,249 compared with DKK -683,391 the year before. Equity in the 2023 report amounted to DKK -356,205.

Gross Profit
DKK -1,276,497
Profit/Loss
DKK -1,290,249
Equity
DKK -356,205
Total Assets
DKK 902,281
Employees
0

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2023--1.3M-1.3M-356K0
2022-1.3M-683K-384K1
2021-1.5M46K299K1
2020-1.7M44K253K1
2019-1.9M65K209K1

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2023

Clovis Oncology Denmark ApS: The 2022 annual report is outNov 16, 2023

Clovis Oncology Denmark ApS has published its annual report for 2022. Gross profit came to DKK 1,268,076, and the net result was DKK -683,391.

Andreas Moin Akhtar joins Clovis Oncology Denmark ApS as directorNov 14, 2023

As of November 14, 2023, Andreas Moin Akhtar is registered as director of Clovis Oncology Denmark ApS.

Marianne Philip steps down as liquidator of Clovis Oncology Denmark ApSNov 14, 2023

As of November 14, 2023, Marianne Philip has stepped down as liquidator of Clovis Oncology Denmark ApS.

Clovis Oncology Denmark ApS exits liquidationNov 14, 2023

On November 14, 2023, Clovis Oncology Denmark ApS exited liquidation.

Marianne Philip joins Clovis Oncology Denmark ApS as liquidatorSep 11, 2023

As of September 11, 2023, Marianne Philip is registered as liquidator of Clovis Oncology Denmark ApS.

Clovis Oncology Denmark ApS enters liquidationSep 11, 2023

On September 11, 2023, Clovis Oncology Denmark ApS entered liquidation.

Paul Edward Gross leaves the board of Clovis Oncology Denmark ApSAug 16, 2023

As of August 16, 2023, Paul Edward Gross has left the board of directors of Clovis Oncology Denmark ApS.

Grant Alan Pius leaves the board of Clovis Oncology Denmark ApSAug 16, 2023

As of August 16, 2023, Grant Alan Pius has left the board of directors of Clovis Oncology Denmark ApS.

Daniel Walter Muehl steps down as chairman of Clovis Oncology Denmark ApSAug 16, 2023

As of August 16, 2023, Daniel Walter Muehl has stepped down as chairman of Clovis Oncology Denmark ApS.

Daniel Walter Muehl steps down as adm. dir. of Clovis Oncology Denmark ApSAug 16, 2023

As of August 16, 2023, Daniel Walter Muehl has stepped down as adm. dir. of Clovis Oncology Denmark ApS.

About Clovis Oncology Denmark ApS

Clovis Oncology Denmark ApS was a Danish company of the type Anpartsselskab based in Allerød, founded in 2017. The company has been dissolved on 5 June 2025. The company was registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company has 1 employee (2023). In 2023, the company reported a gross profit of DKK -1,276,497 and a net result of DKK -1,290,249 compared with DKK -683,391 the year before. Equity in the 2023 report amounted to DKK -356,205.

Source: annual report 2023, Danish Business Authority

Other financial years